prolific liar

119 days ago

Skinbiotherapeutics Presentation – a curate’s egg

"You are not answering the f*cking question" I screamed at my screen as Alyson Levett failed to answer one of the questions I posed. Up until that point I was really quite impressed. So what are the key takeaways from today’s Investor Meet event.

123 days ago

Skinbiotherapeutics: GOTCHA! Incompetent FD Emily Bertram resigns with almost immediate effect

First it was the prolific liar and fraudster Stuart Ashman, then the incompetent chairman Martin Hunt and now I have a third scalp: Emily Bertram who was appointed as CFO  in April 2025 and joined the board in January 2026 has resigned from Skinbiotherapeutics (SBTX) and will leave the company next Tuesday. Another head I demanded has rolled.

131 days ago

Skinbiotherapeutics Letter from the Financial Reporting Council – yet another vindication for the Sherriff of AIM

Some folks are prolific liars. Some folks cheer on prolific liars and some folks get attacked for being a good guy who exposes prolific liars. If you believe that I am the source of all evil like crazy Meg Short at Bloomberg and so deserve to be “destroyed”, here is yet more evidence that I am a good guy and that you are just plain wrong and stupid and a disgrace to your profession.

140 days ago

Tom Winnifrith Bearcast No1: the Skinbiotherapeutics FRAUD

The report and interims are out. I discuss my role in exposing this fraud via the FRC, the nature of the fraud and why the PROLIFIC LIAR and FRAUDSTER Stuart Ashman should be in jail, what is being covered up or not said,  why more heads should roll, the interims, current trading and again what is NOT being disclosed, the risks of a placing and the now current valuation of Skinbiotherapeutics (SBTX).

151 days ago

Skinbiotherapeutics fraud enquiry update: this reads very badly

As I have noted many times, to hoots of derision from small furry rodents, Stuart Ashman’s fanboys and other denialists, if the only matter being investigated by FRP at Skinbiotherapeutics (SBTX) was the fraudulent recognition of accrued income from Croda, thus investigation which started in mid February would have been over by March. Today we have an update.

238 days ago

Skinbiotherapeutrics appoints interim CEO and she looks a very credible hire …but

Any suggestion from the denialists that Skinbiotherapeutics (SBTX) might have over egged the extent of the crimes of disgraced prolific liar and fraudster Stuart Ashman and that there might be a kiss and make up are today put to bed with news that Rachel Parsonage has been appointed as interim CEO. She appears to have a cracking CV but..

243 days ago

Another promise broken by Stuart Ashman & meet his customer, barking Viv from Manchester

It is not a major thing but it raises two issues. On 5th December in an RNS Skinbiotherapeutics (SBTX) promised that its shareholders could quiz the company in an Investor Meet (IMC) session in January. Now Stuart Ashman might, as is his wont, accuse me of being a prolific liar in stating this but you can check out the announcement and I am telling the truth. As for Ashman…

254 days ago

Crazy theories about Stuart Ashman being resigned, no 7, a lawyer writes

The failure of SkinBiotherapeutics (SBTX) to say why Stuart Ashman had been suspended before he resigned as CEO means that there can be no certainty as to the financial position of the company or the veracity of past claims made by Ashman and, as such, anyone buying shares is terribly brave. They may be rewarded they may not be, we shall see. But in thus void there are some crazy theories doing the rounds. A lawyer writes.

318 days ago

Tom Winnifrith Bearcast No 1: A prolific Liar ponders a big fail at the Sam Antar game

I consider today's developments at Versarien (VRS) whose former CEO repeatedly accused me of lying, Skinbiotherapeutics (SBTX) whose CEO's homework has just been marked as a fail by Sam Antar and Nightcap (NGHT) and all the red flags flying today.

318 days ago

Who is a prolific liar then?

The audio clip below is from an interview conducted by a small furry rodent and Stuart Ashman the CEO at Skinbiotherapeutics (SBTX). Natch the defamatory statement is not corrected or challenged by the rodent.